News
BVAXF
0.054
+0.37%
0.000
Weekly Report: what happened at BVAXF last week (0415-0419)?
Weekly Report · 22h ago
BioVaxys Filing Delays Extend MCTO Deadline
TipRanks · 4d ago
Weekly Report: what happened at BVAXF last week (0408-0412)?
Weekly Report · 04/15 11:33
Innovative Fish Contraceptive Vaccine Enters Field Trials
TipRanks · 04/10 17:37
Stocks in play: BioVaxys Technology Corp
SpayVac has partnered with a world leader in the aquaculture space to field test immuno-contraceptive vaccines in farmed rainbow trout. The company is developing a vaccine to be used in the commercial aquatic farming industry. BioVaxys Technology Corp shares are trading up 1%.
Barchart · 04/10 07:54
Weekly Report: what happened at BVAXF last week (0401-0405)?
Weekly Report · 04/08 11:38
BioVaxys Delays Financial Filings, Aims for Compliance
TipRanks · 04/05 00:37
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Is unable to file its audited annual financial statements for the year ended October 31, 2023. The company was granted a management cease trade order on February 29, 2024. The Company's annual filings were required to be made no later than February 28, 2024 .
Barchart · 04/04 19:05
BioVaxys Gains U.S. Patent, Advances Global Filings
TipRanks · 04/03 12:38
Stocks in play: BioVaxys Technology Corp
BioVaxys receives Notice of Allowance from U.S. Patent and Trademark Office for a Patent for inducing an antibody immune response from a low dose volume delivery of a B-cell epitope formulated with DPX™. DPX is a proprietary lipid-based delivery platform.
Barchart · 04/03 08:29
Weekly Report: what happened at BVAXF last week (0325-0329)?
Weekly Report · 04/01 11:35
Weekly Report: what happened at BVAXF last week (0318-0322)?
Weekly Report · 03/25 11:38
Stocks in play: BioVaxys Technology Corp
Announced it intends to complete a non-brokered private placement consisting of up to 15,384,615 units. BioVaxys Technology Corp shares C.BIOV are trading unchanged at $0.08. The company expects to raise up to CAD$1,000,000.
Barchart · 03/25 08:03
BioVaxys Plans Capital Boost with Private Placement
TipRanks · 03/22 21:37
BioVaxys Reports Delay in Financial Filings
TipRanks · 03/21 23:07
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Was unable to file its audited annual financial statements for the year ended October 31, 2023. The company was granted a management cease trade order on February 29, 2024. The Company's annual filings were required to be made not later than February 28, 2024 .
Barchart · 03/21 17:34
Weekly Report: what happened at BVAXF last week (0311-0315)?
Weekly Report · 03/18 11:36
Weekly Report: what happened at BVAXF last week (0304-0308)?
Weekly Report · 03/11 11:32
BioVaxys Receives Cease Trade Order Amid Audit Delays
TipRanks · 03/08 11:37
BioVaxys Continues Bi-Weekly Update Amid Filing Delay
TipRanks · 03/08 11:37
More
Webull provides a variety of real-time BVAXF stock news. You can receive the latest news about Biovaxys Technol through multiple platforms. This information may help you make smarter investment decisions.
About BVAXF
Biovaxys Technology Corp., formerly Lions Bay Mining Corp., is a Canada-based clinical-stage immunotherapeutics company. The Company develops vaccine platforms for SARS-CoV-2 and various cancers.